- Home
- DSP vs CVRX Comparison
DSP vs CVRX Comparison
Compare DSP & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSP
- CVRX
- Stock Information
- Founded
- DSP 1999
- CVRX 2000
- Country
- DSP United States
- CVRX United States
- Employees
- DSP N/A
- CVRX 206
- Industry
- DSP EDP Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DSP Technology
- CVRX Health Care
- Exchange
- DSP Nasdaq
- CVRX Nasdaq
- Market Cap
- DSP 220.3M
- CVRX 203.9M
- IPO Year
- DSP 2021
- CVRX 2021
- Fundamental
- Price
- DSP $10.30
- CVRX $7.82
- Analyst Decision
- DSP Strong Buy
- CVRX Buy
- Analyst Count
- DSP 9
- CVRX 7
- Target Price
- DSP $20.44
- CVRX $14.00
- AVG Volume (30 Days)
- DSP 347.0K
- CVRX 207.2K
- Earning Date
- DSP 08-11-2025
- CVRX 10-28-2025
- Dividend Yield
- DSP N/A
- CVRX N/A
- EPS Growth
- DSP N/A
- CVRX N/A
- EPS
- DSP 0.13
- CVRX N/A
- Revenue
- DSP $318,471,000.00
- CVRX $54,652,000.00
- Revenue This Year
- DSP $16.28
- CVRX $11.32
- Revenue Next Year
- DSP $15.43
- CVRX $18.58
- P/E Ratio
- DSP $77.09
- CVRX N/A
- Revenue Growth
- DSP 30.92
- CVRX 23.11
- 52 Week Low
- DSP $9.07
- CVRX $4.30
- 52 Week High
- DSP $26.33
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- DSP 42.79
- CVRX 55.13
- Support Level
- DSP $9.81
- CVRX $7.22
- Resistance Level
- DSP $10.35
- CVRX $7.96
- Average True Range (ATR)
- DSP 0.43
- CVRX 0.44
- MACD
- DSP 0.16
- CVRX 0.03
- Stochastic Oscillator
- DSP 84.25
- CVRX 82.54
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.